Biden Vows to Fund Biotech to Fight Cancer on 60th "Moonshot
This POTUS committment to fund biotech to fight cancer comes at an optimal time for Big Pharma M&A activities going into 2023, for companies with emerging immuno-oncology agents such as ONCY's immune molecule platform in pelareorep.
https://www.biospace.com/article/biden-vows-to-fund-biotech-to-fight-cancer/